ClinicalTrials.gov
public full text
Public Domain
PK Study of Gefurulimab SC in Healthy Chinese Adult Participants
The primary objective of this study is to characterize the PK properties of a single dose of gefurulimab in healthy Chinese participants.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- DDI Study of Evobrutinib and Carbamazepine#1093433
- Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects#859588
- Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer#1094448
- A Study to Evaluate Long-term Safety of Zanubrutinib Regimens in Participants With B-Cell Malignancies Who Participated in BeiGene Parent Studies of Zanubrutinib#850842
- An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder#1058402
Record · ID 1100953
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive